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The Mycobacterium tuberculosis acid-induced
operon MymA encodes the fatty acyl-CoA synthe-
tase FadD13 and is essential for virulence and
intracellular growth of the pathogen. Fatty acyl-CoA
synthetases activate lipids before entering into the
metabolic pathways and are also involved in trans-
membrane lipid transport. Unlike soluble fatty acyl-
CoA synthetases, but like the mammalian integral-
membrane very-long-chain acyl-CoA synthetases,
FadD13 accepts lipid substrates up to the maximum
length tested (C26). Here, we show that FadD13
is a peripheral membrane protein. The structure
and mutational studies reveal an arginine- and
aromatic-rich surface patch as the site for membrane
interaction. The protein accommodates a hydro-
phobic tunnel that extends from the active site
toward the positive patch and is sealed by an argi-
nine-rich lid-loop at the protein surface. Based on
this and previous data, we propose a structural basis
for accommodation of lipid substrates longer than
the enzyme and transmembrane lipid transport by
vectorial CoA-esterification.
INTRODUCTION
Fatty acids are activated before being introduced into different
metabolic pathways. This is universally achieved by fatty
acyl-CoA synthetases (ACSs), usually denoted FadD or FACS
proteins in bacteria. ACSs activate fatty acids, and other hydro-
phobic substrates, by a two-step mechanism, schematically
illustrated in Figure 1. First, the substrate is reacted with ATP,
forming an acyl-adenylate intermediate (acyl-AMP) with the
concomitant release of pyrophosphate. The acyl-AMP inter-
mediate is subsequently reacted with CoA to produce a fatty
acyl-CoA thioester, the substrate for numerous anabolic
and catabolic pathways, including membrane biogenesis. The
central position in lipid uptake and metabolism also associates
the ACS proteins with lipotoxicity and conditions, such as insulin
resistance, although the direct biochemical connection remains
to be established (Li et al., 2010).1062 Structure 20, 1062–1070, June 6, 2012 ª2012 Elsevier Ltd All riThree main groups of soluble ACS enzymes have been
categorized based on their ability to activate different length
substrates: short- (C2–C4), medium- (C4–C12), and long- (C12–
C22) chain ACSs. Enzymes from the different groups share
a two-domain structure with a common fold and show confor-
mational changes and domain movements between the steps
of the mechanism (Figure 1). The proteins form substrate-
binding pockets of suitable size, which explains the substrate-
size specificity and, importantly, the inability to accommodate
longer substrates (Hisanaga et al., 2004; Kochan et al., 2009;
Reger et al., 2008). The ACS protein groups can be partly as-
signed based on sequence similarity, but substrate specificity
cannot be conclusively defined and must be experimentally
determined (Black and DiRusso, 2003; Khurana et al., 2010;
Watkins et al., 2007, 2008).
There is also a group of very-long-chain ACSs, mainly charac-
terized in eukaryotes (denoted ACSVL; Mashek et al., 2004;
Watkins, 2008). ACSVL enzymes have the capacity to accept
lipids longer than C22, usually tested by the ability to activate
C24 substrates. An interesting conundrum that arises when
approaching lipid substrates of this size is that the length of
the acyl chain is well beyond the expected dimensions of the
protein, likely precluding the formation of a sufficiently large
internal hydrophobic pocket to accommodate the substrate.
Unlike other ACS proteins, the ACSVLs generally appear to be
integral membrane proteins (Watkins, 2008; Gimeno, 2007;
Uchiyama et al., 1996). A second subfamily ‘‘bubblegum’’ has
also been identified and different members have been assigned
as integral (Fraisl et al., 2004, 2006), or peripheral (Steinberg
et al., 2000), membrane proteins. Interestingly, ACSVL enzymes
were first identified as fatty acid transport proteins (denoted
FATP family), moving exogenous lipids over the membrane
(Hirsch et al., 1998; Schaffer and Lodish, 1994), thus linking
assimilation and activation of fatty acids. It is still not completely
resolved if the transport function is distinct from the activation
or if it is a consequence of metabolic capture of the lipid by
CoA-esterification on the cytosolic side, leading to net vectorial
transport (DiRusso et al., 2008; Gimeno, 2007; Watkins, 2008).
No structure is presently available for a full-length ACSVL, likely
because of the difficulties associated with membrane protein
production and crystallization.
Mycobacterium tuberculosis is the causative agent of tuber-
culosis (TB). Despite the existence of antibiotic treatments and
a vaccine, it remains one of the worst global killers with an
estimated 1.4 million yearly deaths and a third of the world’sghts reserved
Figure 1. Schematic General Mechanism in
ACS Proteins
Binding of ATP induces structural changes
promoting binding of the hydrophobic substrate.
Formation of an acyl-adenylate intermediate
induces a 140 rotation of the small domain and
binding of CoA for production of the final product,
a fatty acyl-CoA thioester.
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resistant (MDR) and extensively drug-resistant (XDR) strains. It
is estimated that 1.3 million MDR-TB cases will have to be
treated between 2010 and 2015 at a projected cost of over
US$16 billion (WHO, 2010). Identification of new anti-TB drugs
and drug targets is imperative (WHO, 2011).
The bacterium has a unique lipid-rich cell envelope that is key
to its virulence, inherent drug resistance, and ability to multiply
within the macrophage (Cole et al., 1998). The envelope consists
of several complex lipids, in particular mycolic acids (MAs), long-
chain (C60-C90) b-hydroxy fatty acids. For this reason, lipid
synthesis is a key drug target for present drugs and future drug
design efforts (Barry et al., 2007; Hoffmann et al., 2008; Kaur
et al., 2009). A number of studies show that the MymA operon,
comprising seven proteins, is important for virulence and
production of envelope lipids. Removal of the transcriptional
regulator (VirS) or disruption of the first gene in the operon leads
to altered morphology of the cell wall, fewer MAs and an altered
MA composition, and an increased sensitivity to antibiotics,
detergents, and acidic pH (Singh et al., 2003, 2005a, 2005b). In
addition, the MymA-encoded mRNAs are the most highly
induced of all when bacteria are grown under acidic conditions
in order to mimic the environment of the phagosome (Fisher
et al., 2002). It has also been shown that the operon is required
for in vivo growth of M. tuberculosis in macrophages (Cheruvu
et al., 2007) and that the encoded proteins are highly upregulated
in phagocytosed bacteria (Singh et al., 2003).
M. tuberculosis encodes no less than 36 ACS homologs,
denoted as FadD1–FadD36. A subset of these has also been
shown to catalyze only the first step of the reaction (Arora
et al., 2009; Trivedi et al., 2004). The FadD proteins thus play
a central role in supporting the diverse and extensive lipid
metabolism of the organism. FadD13 has attracted particular
attention as a putative drug target because of its location in
theMymA operon and the biochemical function as a node point
in lipid metabolism (Jatana et al., 2010; Khare et al., 2009; Singh
et al., 2003, 2005a, 2005b; Cheruvu et al., 2007; Fisher et al.,
2002). M. tuberculosis FadD13 has been thoroughly biochemi-
cally characterized, both in terms of substrate specificity and
effects of protein variants on catalytic parameters (Khare et al.,
2009). FadD13 can accept substrates of different lengths and
the activity increases with lipid length up to the limit tested
(C26) (Khare et al., 2009), functionally placing it firmly among
the ACSVL enzymes. Interestingly, unlike other ACSVL proteins,
FadD13 is predicted to be a soluble protein. Homology models
have been produced (Jatana et al., 2010; Khare et al., 2009),
but a rationale for how the enzyme is able to accommodate lipid
substrates significantly longer than the expected distance from
the active site to the protein surface is still lacking.Structure 20, 10To gain insight into substrate accommodation, as well as to
provide a foundation for drug design against M. tuberculosis,
we present here the 1.8 A˚ crystal structure of M. tuberculosis
FadD13, to our knowledge, the first structure of a full-length
ACSVL enzyme. We also show that FadD13 associates to the
membrane when expressed in Escherichia coli and that the
interaction can be partially reversed under certain buffer condi-
tions, such as high concentrations of salt or phosphate or a
high pH. The structure reveals a single exposed positively
charged surface patch, rich in arginines and aromatic residues.
This patch is shown to be the location for membrane interac-
tion based on mutational studies. The protein contains a hydro-
phobic tunnel protruding from the active site toward the positive
patch, capped at the surface by an arginine-rich lid-loop. Based
on this and previous data, we propose a structural basis for the
accommodation of lipid substrates longer than the enzyme and
vectorial lipid CoA-esterification by ACSVL enzymes.
RESULTS
FadD13 Is a Peripheral Membrane Protein
Unlike canonical ACSVL proteins, the FadD13 protein sequence
does not possess properties that would suggest a hydrophobic
anchoring to the membrane. We hypothesized that FadD13
could still associate to the membrane as a peripheral membrane
protein, reversibly interacting through charge and/or moderately
hydrophobic interactions.
To test this hypothesis, we overexpressed the protein in
E. coli. After mechanical disruption of the cells, we prepared
soluble and membrane fractions (see Experimental Procedures).
The membrane fraction was resuspended and washed with
buffer (803 the pellet volume) with different salt concentrations
and pH before finally being repelleted by ultracentrifugation.
The repelleted membrane fractions were dissolved in detergent
(FC-12 or DDM), applied to an IMAC column to capture any
membrane-associated FadD13 protein, and finally analyzed by
SDS-PAGE. As shown in Figure 2, when membranes were
washedwith buffer at physiological pH and 150mMNaCl, a large
amount of FadD13 remained attached to the membrane and
could be isolated upon membrane solubilization (per liter of
culture, about 2 mg of pure FadD13 was recovered from isolated
membranes). The amount of FadD13 that was isolated from the
membrane fraction was reduced to about half when membranes
were prewashed with a high-pH (pH 11) buffer or with buffer
containing 200 mM phosphate. Similarly, a high-salt (NaCl)
concentration during the membrane wash step also reduced
the amount of protein isolated by approximately 40%. The pro-
tein is highly overexpressed and a significant amount of protein
could also be isolated from the soluble fraction. Together, these62–1070, June 6, 2012 ª2012 Elsevier Ltd All rights reserved 1063
Figure 2. FadD13 Associates to the Membrane
Coomassie blue-stained gel showing the protein that remains bound to the
membrane fraction after it has been washed with the buffers indicated above
the lane. After membrane isolation, themembrane pellet was resuspended and
washed twicewithbufferwithvaryingcomposition (text) beforebeing repelleted
and solubilized in detergent to isolate the protein associated to the membrane
using IMAC affinity chromatography. Washes with phosphate, alkaline pH, or
high salt reduced the amount of FadD13 associated to the membrane.




Cell parameters: (A˚) 57.00; 57.00; 249.18
() 90; 90; 120
Resolution (A˚) 32–1.80 (1.90–1.80)
Completeness (%) 96.7 (87.7)
Redundancy 3.06 (2.15)
Rmeas (%) 6.4 (60.4)
I/sI 12.71 (2.01)
Table 2. Refinement Statistics
Resolution (A˚) 19.86–1.80 (1.846–1.800)
No. of unique reflections 41,486
No. of reflections in test set 2,205
Rwork (%) 16.2 (23.7)




rmsd from ideal values
Bond length (A˚) 0.019
Bond angle () 1.705
Ramachandran outliers, % 0.4
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but not as an integral membrane protein. The relative ratio
between the soluble and membrane fractions differs depending
on the buffer conditions, indicating an equilibrium between
amembrane-bound and soluble state. Given the high expression
obtained, the relative ratios may also be influenced by a possible
saturation effect of the membrane.
Overall Structure of FadD13
Purification under high-salt conditions allowed us to produce
a protein sample that was homogenous and could be crystal-
lized. The 1.8 A˚ resolution structure of FadD13 includes residues
2 to 502; see Tables 1 and 2 for data and refinement statistics.
No electron density was observed for parts of a loop structure
(residues 166–168) and the last residue of the protein (Lys
503). Similar to previous structures of ACS enzymes, the protein
consists of two domains. The larger N-terminal domain (residues
1–395) is connected via a six-amino acid linker to the smaller
C-terminal domain (residues 402–503; Figure 3A; Figure S1
available online). The relative orientation of the domains is
consistent with the apo-form of shorter-chain ACS proteins (Hi-
sanaga et al., 2004; Kochan et al., 2009; Reger et al., 2008). As in
these proteins, theN-terminal domain folds into an a+ b topology
and can be further divided into two subdomains. The smaller
C-terminal domain has one two-stranded and one three-
stranded antiparallel b sheet, with three helices at its faces.
Active Site Structure
The active site is located close to the hinge region between
the N-and C-terminal domains and consists of three subsites.1064 Structure 20, 1062–1070, June 6, 2012 ª2012 Elsevier Ltd All riThe ATP binding site is open and basic in nature (Figure 3B).
FadD13 contains both ATP/AMP binding signature motifs
normally found in ACS proteins, the first sequence
(163YTSGTTGHPKGV174) is partially disordered in the structure,
likely because of the absence of bound ATP. The sequence
corresponding to the second motif (300GYALTE305), involved in
the binding of the adenine group, is structurally virtually identical
to those of other ACS proteins. The CoA binding site in ACS
proteins is formed in the junction between the domains upon
a 140 rotation of the C-terminal domain after the initial adenyla-
tion step (Hisanaga et al., 2004; Kochan et al., 2009; Reger et al.,
2008; Figure 1, last step). Modeling of the CoA-bound confor-
mation based on homologous structures shows a conserved
CoA binding site. The sequence and structural features thus
suggest that FadD13 will bind the ATP and CoA substrates in
the samemanner as previously described ACS proteins. Despite
extensive trials, we have been unsuccessful in obtaining fatty
acid or ATP analog complex structures of FadD13. The lack of
success may be due to the high-salt conditions needed to
produce a crystallizable sample or because membrane interac-
tion is needed to promote substrate binding (see Discussion).Arginine- and Aromatic-Rich Surface Patch and Lipid
Binding Site
The lipid binding site and surrounding structure display a number
of interesting features and differences compared to shorter-
chain ACS proteins. For example, in the long-chain ACS fromghts reserved
Figure 3. Overall Structure ofM. tuberculosis FadD13
(A) Rainbow coloring from blue (N-terminal) to red (C-terminal), showing the two-domain structure.
(B) Surface contact potential showing the basic ATP-binding cavity (center).
(C) Hydrophobic tunnel protruding from the ATP binding site toward the protein surface. The channel is capped at the surface by a loop structure (red).
See also Figure S1.
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Very-Long-Chain Fatty Acyl-CoA SynthetaseT. thermophilus (ttLC-FACS), binding of AMP-PNP induces
a rotamer change of Trp234, to interact directly with the beta
phosphate of AMP-PNP. This shift opens a ‘‘dead-end branch’’
which houses the omega end of its substrate myristic acid
(C14), and positions the lipid head group for activation (Hisanaga
et al., 2004). A corresponding tryptophan residue is not present
in FadD13 and the opening of a similar lipid-accommodating
cavity is not expected to occur. In apo FadD13 there is a cavity
in a similar position, but this is only large enough to house
substrates of maximally around 14 carbon atoms in length, and
thus not nearly large enough to accommodate a C26 substrate.
However, in apo FadD13, a hydrophobic cavity also extends
from the ATP binding site toward the protein/solvent interface
where it narrows and is sealed at the surface (Figure 3C). The
cavity protrudes between the parallel beta sheet b9-b14 and
helices a8-a9 (gray in Figure 4) and is lined by hydrophobic
residues, leaving only a small number of possible H-bond
interactions (mainly from the protein backbone). Each of the
secondary structure elements, lining the fatty acid cavity, end
in arginine-rich loops at the protein surface (Figure 4) and
make up the center of a larger patch, rich in arginines and
aromatic residues that provides the only positively charged
surface on this negatively charged protein (theoretical pI 5.1),
aside from the ATP-binding cavity (Figure 5A). The patch
comprises 14 surface-exposed arginines, and ten hydrophobic
aromatics (five tyrosines, three phenylalanines, and two trypto-
phan residues; Figure 5B). Of particular interest is a loop struc-
ture (residues 193–199) that links a8 and the central strand of
the b sheet (red in Figures 4 and 5B) and seals the hydrophobic
cavity at the protein surface. The loop is located centrally in the
positively charged patch and itself contains one tyrosine and
three arginine residues.
The Arginine- and Aromatic-Rich Surface Patch Is
Involved in Membrane Binding
Given the particular chemical nature of the surface patch, we
suspected that it is involved in membrane binding. Aromatic
residues are the ones most prone to bind to lipid bilayer (hydro-Structure 20, 10phobic) interfaces (Wimley and White, 1996), whereas arginines
yield affinity to both zwitterionic and anionic lipid polar
headgroups. Both types are present in lipid-binding sites in
membrane proteins (Palsdottir and Hunte, 2004) and peptides
(Yang et al., 2003). To investigate this, we used a screening
protocol for binding of the wild-type protein to liposomes (of
various compositions) and to commercial membrane lipid
strips, as described in (Ge et al., 2011). The protein revealed
a weak binding to (zwitterionic) phosphatidylcholine which was
enhanced somewhat by mixing in the anionic phosphatidyl-
glycerol and especially by cardiolipin, both present in
M. tuberculosis (Sartain et al., 2011). However, several strip lipid
spots containing various single (100%) anionic lipids did not
confer binding. These findings were quantified by surface plas-
mon resonance (SPR) analyses, monitoring the binding of the
wild-type protein, and a quintuple residue variant of the protein,
where the charge of the patch had been reduced, whereas its
hydrophobicity was increased (R9A, R17A, R195A, R197A,
R244A). The interaction to a phosphatidylcholine:cardiolipin
70:30 model membrane bilayer-surface coated sensor chip
was investigated using a BSA-coated surface as the reference
(Figures 6, S2A, and S2B). The data show that both wild-type
and mutant proteins bind to the model membrane surface in
a concentration dependent manner, consistent with the binding
observed to the E. colimembrane, and ruling out the requirement
for additional proteins for membrane interaction. Reducing plus-
charge and increasing hydrophobicity of the surface patch led
to an increase in total binding to the membrane surface. The
fact that the strength of the membrane binding is altered when
altering the patch shows that it is involved in the binding. Even
by this rather extensive mutagenesis, removing positive charges
that are likely important to initially recruit the protein to the
membrane, it is clear that the membrane association of the
enzyme was not prevented. This may not be very surprising,
considering the large size of the patch and the great number
of involved amino acids and potential binding motifs (e.g., only
five out of 14 arginines were removed). The fact that the associ-
ation in total (including the contribution from both on- and62–1070, June 6, 2012 ª2012 Elsevier Ltd All rights reserved 1065
Figure 4. Stereo Figure Showing the Arginine-Rich
Lid Loop in Red, Capping the Hydrophobic
Channel at the Protein Surface
(A and B) The channel is lined by side chains provided by
a parallel beta sheet and two helices, in gray.
Structure
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hydrophobic interactions to keep the protein bound at the
membrane.
Structural Basis of Catalytic Properties in Protein
Variants
In a recent study, Khare and colleagues (Khare et al., 2009)
investigated the catalytic properties of numerous FadD13
protein variants, of which the most important are discussed
here. The K172A protein variant shows 3 fold lower kcat and
10-fold increase in Km for ATP, whereas the K487A variant
shows 30-fold lower kcat. K172 is located in the first ATP-
binding signature motif, whereas K487 is located in a loop of
the C-terminal domain. When ATP is modeled into FadD13 these
residues form charge-charge interactions with the phosphates
and are thus likely directly involved in ATP binding (Figure S1A).
W377 is partially surface exposed and located distant from the
substrate-binding sites, still the W377A protein variant show
20-fold reduction in both kcat and Vmax. The structure reveals
that W377 forms a small hydrophobic core, linking three
secondary structure elements (Figure S1B) and its importance
is likely due to structural integrity of the enzyme. The V209D,
A211G, A302G, and D382A protein variants all primarily influ-
ence Km for the lipid substrate. V209D, A211G, and D382A
decrease the binding affinity by2-, 2-, and 4-fold, respectively,
whereas A302G increases it 2.5-fold. All these residues influ-
ence the secondary structure elements and the internal surface
of the lipid-binding tunnel entrance at the ATP-binding site,
D382 via an H-bond to Y301 (Figure S1C).
DISCUSSION
Unlike most other biological molecules, lipids are apolar and
show very low water solubility. This presents particular chal-1066 Structure 20, 1062–1070, June 6, 2012 ª2012 Elsevier Ltd All rights reservedlenges for the largely water solution-based
chemistry of biological systems. Lipids partition
into membranes and must be activated and
carried by specific lipid-binding proteins to be
entered into cellular metabolism. This problem
is accentuated for very long lipids that are not
readily accommodated within the hydrophobic
core of proteins. One possible solution to this
problem is to allow part of the lipid to reside in
the membrane, while the other part is enzymat-
ically modified. This mechanism appears to be
in effect in the integral-membrane ACSVL
enzymes. These enzymes also function in the
transmembrane transport of lipids (Hirsch
et al., 1998; Schaffer and Lodish, 1994), linking
assimilation and activation of fatty acids. At
least one mechanism for net transfer appearsto be metabolic capture of the lipid by CoA-esterification on
the cytosolic side (Watkins, 2008; DiRusso et al., 2008; Gimeno,
2007).
FadD13 activates lipids, with increasing activity, up to the limit
tested (C26) (Khare et al., 2009), firmly placing it functionally
among the ACSVL proteins. The structure confirms that
FadD13 is unable to accommodate substrates of this length
within the protein in any way similar to the binding modes
previously observed (Hisanaga et al., 2004; Kochan et al.,
2009; Reger et al., 2008). However, here we also show that
FadD13 is a peripheral membrane protein, likely reversibly asso-
ciating with the membrane. The protein surface contains
a distinctive patch, rich in arginines and aromatics, which we
show is involved in the membrane association. Arginines and
aromatic residues are commonly found in protein/membrane
interfaces and also make up distinct lipid-binding motifs, that
is, for cardiolipin aromatic residues are quite common (Palsdottir
and Hunte, 2004). However, this plus-charged patch is located
surrounded by many negatively charged residues (see Fig-
ure 5A), so both attractive and repellent forces by the negatively
charged membrane bilayer surface, act on the protein (14e net
charge), cf. Mulgrew-Nesbitt et al. (2006). It is likely that a critical
balance between quenching ions (salts), local pH, and local lipid
minus charge concentration, will affect the amounts of protein
associated (‘‘attracted’’) to the bilayer or staying in the in the
cytoplasm (‘‘repelled’’). It is well established that, for example,
the anionic cardiolipin can have a heterogenous lateral distribu-
tion in bacterial membranes.
The structure also reveals a hydrophobic tunnel, extending
from the active site toward the positively charged surface patch,
capped by an arginine-rich lid-loop. Based on these structural
and biochemical features we hypothesize that the lid loop
opens upon interaction with the membrane, allowing binding of
substrate with the lipid tail remaining partly in the membrane
Figure 5. Details of the Arginine-Rich Surface Patch
(A) Surface contact potential.
(B) Positioning of arginines and aromatic side chains in relation to the cavity-
lining secondary structure elements (gray) and the lid loop (red).
Figure 6. Binding Analysis by SPR
A 75 mM sample of FadD13 (solid lines) and the R9A, R17A, R195A, R197A,
R244A variant (dotted lines) was injected over a DOPC/CL (70:30, mole:mole)
surface, association and dissociation was followed for 5 min, respectively.
Duplicate experiments are shown (gray and black). Sensorgrams show values
subtracted against a BSA-coated reference surface.
See also Figure S2.
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the protein surface may also contribute to recruit fatty acid
substrates to the enzyme. A partial accommodation of the
substrate within the membrane is also consistent with the
enzyme’s observed nonstrict specificity for fatty acid chain
length (Khare et al., 2009). Despite significant effort we have
not been able to obtain lipid complex structures by cocrystalliza-
tion or soaking, possibly because of the need for a membrane
interaction to induce a substrate-binding conformation of the
hydrophobic channel.
M. tuberculosis FadD13 perform the same function as the
mammalian integral-membrane ACSVL enzymes but an impor-
tant remaining question is if FadD13 can be used also as a struc-
tural model for the catalytic domains of these. Even though
phylogenetic analysis indicate a common ancestry (Watkins
et al., 2007), a conclusive assignment of the catalytic domains
of ACSVL enzymes to the same fold as other ACS proteins has
been hampered by the borderline sequence similarity (Uchiyama
et al., 1996; Hirsch et al., 1998; Lewis et al., 2001; Obermeyer
et al., 2007; Richards et al., 2003). However, benefiting from
the more sophisticated bioinformatic tools and larger sequence
and structure base presently available, this assignment now
appears unambiguous. In addition to convincing sequence
alignment reliability scores for homology, structure prediction/
fold recognition using all tested methods, including, for ex-
ample, Swissmodel (Arnold et al., 2006; http://swissmodel.Structure 20, 10expasy.org/), Psipred (Bryson et al., 2005; http://bioinf.cs.ucl.
ac.uk/psipred/), and threading using the Wurst server (Torda
et al., 2004; http://www.zbh.uni-hamburg.de/wurst), suggest
this fold with very high confidence scores. The membrane-
bound ACSVLs commonly contain N-terminal extensions com-
pared to FadD13. Experiments and topology/hydrophobicity
predictions suggest that the most common architecture of
ACSVL proteins include one N-terminal transmembrane helix
and other hydrophobic parts of the protein that provide addi-
tional interfacial anchoring sites to the membrane (Lewis
et al., 2001; Obermeyer et al., 2007; Richards et al., 2003).
The hydrophobic segments of these proteins are located mainly
in the N-terminal half of the sequence, consistent with the
membrane interaction geometry as proposed here for FadD13
via mainly hydrophobic interactions. This is also consistent
with the topological models previously proposed for ACSVL/
FATP proteins (Lewis et al., 2001; Obermeyer et al., 2007;
Richards et al., 2003). For the reasons described above, we
propose that the structure and membrane association topology
of FadD13 is a good general model for the catalytic domains of
the integral membrane ACSVL enzymes.
From a lipid metabolism perspective, the linking of transmem-
brane transport and activation of lipids is particularly interesting.
In the original publications defining the group called fatty acid
transport proteins (Hirsch et al., 1998; Schaffer and Lodish,
1994), now known to be ACSVL enzymes, one M. tuberculosis
homolog (FadD6) was identified. However, recently it was shown
that disruption of another homolog, FadD5, gives an attenuated
strain that is impaired in utilizing mycolic acids provided in the
growth medium as a carbon source. No difference in growth
rate was observed when shorter-chain fatty acids such as palmi-
tate (C16) or oleate (C18:1 cis-9) were provided (Dunphy et al.,
2010). It thus appears that more ACS variants than initially
thought may be capable of specific lipid transport. Out of the
36 FadDs in M. tuberculosis FadD5 is the closest sequence
homolog (37% identity) to FadD13, described here, providing
additional clues to the exact metabolic context of the MymA
operon, known to influence virulence, lipid metabolism and62–1070, June 6, 2012 ª2012 Elsevier Ltd All rights reserved 1067
Figure 7. Proposed Model for Catalysis and Lipid Accommodation
in FadD13 and ACSVL Enzymes
The anchoring to the membrane may be polar and reversible (FadD13)
or hydrophobic and permanent (mammalian integral-membrane ACSVL
enzymes, N-terminal transmembrane segments, commonly found in ACSVL
enzymes, are indicated with a dashed line). Large lipid substrates are ex-
pected to partition to the membrane and may be membrane lipids or originate
intracellularly or extracellularly. Net vectorial transport is achieved by meta-
bolic capture as the acyl-CoA thioester is formed intracellularly.
Structure
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substrate is likely a feature that should be considered when
designing inhibitors for these proteins and can possibly be ex-
ploited to improve specificity for ACSVL enzymes.
EXPERIMENTAL PROCEDURES
Cloning, Variant Construction, Protein Expression, and Purification
The gene encoding FadD13 was cloned from theM. tuberculosis strain H37Rv
into the pET-46 Ek/LIC vector using ligation-free cloning, introducing an
N-terminal His6-tag. The resulting plasmid pET-46/FadD13 was transformed
into E. coli BL21(DE3) after sequence verification. The cells were grown in
TB medium supplemented with carbenicillin at 37C to A600 = 0.8  1.0, and
overexpression was induced by 0.5 mM isopropyl thio-b-d-1-galactoside
(IPTG) at 20C overnight. Cells were collected, and periplasmic material was
removed before lysis (Magnusdottir et al., 2009). The protein was purified by
IMAC (immobilized metal affinity chromatography) using Ni-loaded profinity
resin (Biorad, Hercules, CA, USA) in 20 mM HEPES (pH 7.5), 500 mM NaCl,
10% glycerol, 10 mM imidazole, and 0.5 mM TCEP and washed with 25 mM
imidazole before elution with 400 mM imidazole. The second purification
step, size-exclusion chromatography was done on a HiLoad 16/60 Superdex
200 (GE Healthcare, Waukesha, WI, USA) at an increased salt concentration,
600 mM NaCl. The protein was concentrated to 11 mg/ml concentrated in a
vivaspin 30K (Sartorius Biotech, Go¨ttingen, Germany) and was finally stored
in 20 mM HEPES (pH 7.5), 600 mM NaCl, 10% glycerol, and 0.5 mM TCEP.
A 5-point protein variant was constructed by substitution of five arginines
into alanine residues (R9A, R17A 195A, R197A, R244A) to create a less
charged and more hydrophobic surface patch. The sequence verified
synthetic gene, provided by GeneArt, was and moved into the expression
vector and used for protein production as described previously.
Membrane Association Studies
Transformed cells were grown in Terrific broth media at 37C. Overexpression
was initiated with 0.1 mM isopropyl-beta-D-thiogalactopyranoside (Anatrace,
Maumee, OH, USA) at OD600 0.9–1.0 and carried out at 20
C for 18 hr. The
cells were harvested by 15 min. centrifugation at 7500xg. Cells were resus-1068 Structure 20, 1062–1070, June 6, 2012 ª2012 Elsevier Ltd All ripended in 20 mM HEPES (pH 7.5), 150 mM NaCl, 0.5 mM TCEP, Benzonase,
and EDTA-free protease inhibitor cocktail (Buffer A) and lysed with three
rounds of freeze thawing followed by emulsiflex (high-pressure homogeniza-
tion apparatus; Avestin Inc., Ottawa, Ontario, Canada) treatment. The lysate
was clarified by centrifugation at 11000xg for 30 min and the supernatant
divided into three equal fractions (A, B, and C). The membranes were pelleted
by ultracentrifugation at 140000xg for 1 hr. The resulting pellets were resus-
pended in buffers with varying composition; A in Buffer A; B in 200 mM
Na-phosphate buffer (pH 7.5); and C in 100 mM Na2CO3 (pH 11). All samples
contained 150 mM NaCl and were supplemented with 0.5 mM TCEP and
EDTA-free protease inhibitor cocktail. After 1 hr of gentle shaking at 4C,
the membranes were repelleted by ultracentrifugation and again washed by
resuspension in the respective buffer and left on ice for one hour. The
membranes were repelleted and solubilized with 1% detergent FC-12
(foscholine-12) in Buffer A supplemented with 20 mM imidazole for three hours
at 4C with gentle stirring. Unsolubilized material was pelleted by ultracentri-
fugation and solubilized material was loaded on an Ni-loaded NTA-resin
(Qiagen, Venlo, Switzerland). Bound material was washed with Buffer A
supplemented with 20 mM imidazole before elution with Buffer A supple-
mented with 500 mM imidazole. All fractions of the IMAC purification were
followed by SDS-PAGE (4%–12% Bis-Tris, Invitrogen) and stained with
Coomassie blue.
To see the effect of increasing salt concentrations in the wash steps,
FadD13 was expressed as described previously; the cells were divided into
four equal parts, lysed, and washed as described previously but varying
the amounts of salt of Buffer A (0 mM, 150 mM, 300 mM, and 600 mM
NaCl). Prior to solubilization, all membrane pellets were resuspended in Buffer
A supplemented with 20 mM imidazole and with a final NaCl concentration of
600 mM in all samples. Detergent (DDM) (n-Dodecyl-b-maltoside) was added
to each sample to a concentration of 1% and left to solubilize on gentle stirring
over night at 4C. Unsolubilized material was pelleted and the detergent
solubilized membrane fraction was purified as described previously. Also
here, all fractions of the Ni-IMAC were followed by SDS-PAGE.
Liposome Preparation
Lipids were dissolved in chloroform and mixed to yield a 10 mM mixture of
dioleoyl-phosphatidylcholine (DOPC) and cardiolipin (CL) at a ratio of 70:30
(mole:mole). The solvent was evaporated under N2 gas, and the resulting lipid
film was further dried under vacuum overnight. The dried lipid film was
dispersed in running buffer (10 mM HEPES (pH 7.5), 150 mM NaCl, 5%
glycerol, and 0.1% DMSO) by extensive vortexing. The hydrated lipids were
incubated for 1 hr at room temperature. Liposomes were prepared using
a 1 ml extruder (Avestin LiposoFast), and the lipid suspension was pushed
through 0.1 mm membrane 21 times to ensure unilamellar vesicles.
Surface Plasmon Resonance Binding Analysis
The binding analysis was performed using a Biacore3000 instrument with a
L1 Sensor Chip (GE Healthcare) and 10 mM HEPES (pH 7.5), 150 mM NaCl,
5% glycerol, and 0.1% DMSO as running buffer. The sensor chip surface
was washed with 40 mM n-octyl-b-glycoside (20 ml, 20 ml/min) prior to lipo-
some injection. Liposomes were injected (30 ml, 3 ml/min) and immobilized to
the surface, yielding a response level of 1800–2700 RU. Unbound vesicles
were washed away with running buffer (125 ml, 50 ml/min). The surface was
allowed to stabilize (40 ml, 5 ml/min) prior to sample injection. Bovine serum
albumin, BSA (40 mg/ml), was covalently immobilized via amine coupling and
used as a reference surface. Sample was injected over the surfaces (25 ml,
5 ml/min), and association and dissociation was followed for 5 min, respec-
tively. Thereafter, the surface was regenerated with 50% 2-propanol in
50 mM NaOH.
Crystallization, Data Collection, and Structure Determination
FadD13 was crystallized in the presence of 10 mM CoA and 1 mM ATP, using
the sitting drop vapor diffusion method. The protein was first mixed with ATP
and reached a concentration of 11mg/ml. In the final crystallization conditions,
0.5 ml protein solution was mixed with 1.5 ml reservoir solution containing
100 mM HEPES (pH 7.3), 20 mM MgCl2, 23% polyacrylic acid, and 10 mM
CoA; crystals grew in 1–2 days. Attempts to setup crystallization in the
absence of either ATP or CoA generated none or were poorly diffractingghts reserved
Structure
Very-Long-Chain Fatty Acyl-CoA Synthetasecrystals. Crystal were cryoprotected by soaking for 10 min in mother liquor
supplemented with 60% w/v Na2 malonate. Data were collected to 1.8 A˚ at
100 K at beamline ID14-2 at the ESRF synchrotron in Grenoble, France.
Diffraction data were processed and scaled using MOSFLM (Leslie, 1992)
and SCALA from the CCP4 suite (Collaborative Computational Project,
Number 4, 1994). Data statistics are presented in Table 1. Initial phases
were obtained using molecular replacement with Phaser (McCoy et al.,
2007), using the Thermus thermophilus tt0168 structure (Protein Data Bank
[PDB] id 1ULT) as the template for model generation. The initial molecular
replacement solution was improved with Phenix Autobuild (Adams et al.,
2010) and Arp/Warp (Perrakis et al., 1999), followed by cycles of manual
building in COOT (Emsley and Cowtan, 2004). Refinement was carried out in
Refmac5 (Vagin et al., 2004). Model statistics are given in Table 2. Molecular
surfaces and cavities were calculated using the program MOLE (Petrek
et al., 2007). All figures were made in Pymol (http://www.pymol.org). The
model and structure factors have been deposited in the PDB (id 3R44).
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